Vaccine - EpiLinks

WORKSHOP ON DENGUE VACCINATION IN THE CONTEXT OF A TEST-AND-VACCINATE STRATEGY IN BRAZIL

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Strategic and operational guidelines and tools, Vaccine

Regional brainstorming for the development of guidelines for the implementation of the dengue vaccine. The state of Paraná in Brazil has conducted community-based campaigns for dengue vaccination during 2016-2018. Following the new Sanofi Pasteur product label and...

EXPERT MEETING FOR DENGUE VACCINE IMPLEMENTATION IN LATIN AMERICA

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Vaccine

For a better understanding of the new recommendations for the dengue vaccine implementation. The 6th Expert meeting on dengue vaccine implementation in Latin America was held June 22 and 23 2018 in Lima, Peru. The meeting convened a permanent group of Latin America...

TECHNICAL SUPPORT FOR THE INTRODUCTION OF ROTAVIRUS VACCINE IN THE DEMOCRATIC REPUBLIC OF CONGO

by arnaud debuyzer | 25 May, 2022 | Logistics and health systems, Operational research and evaluation, Strategic and operational guidelines and tools, Vaccine

A logistical feasibility assessment. The rotavirus vaccine prevents gastrointestinal infections, which are common causes of fatal diarrheal diseases in children. The DRC has decided to offer this vaccine to all children in the country. EpiLinks has provided technical...

TECHNICAL SUPPORT TO DENGUE VACCINE IMPLEMENTATION: INFORMATION FOR DECISION-MAKING

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Strategic and operational guidelines and tools, Vaccine

Since December 2015, dengue is a vaccine-preventable disease. What are the key factors to consider for vaccine introduction. The CYD-TDV vaccine (commercial name Dengvaxia®) is a dengue tetravalent vaccine (live attenuated), that has been licensed for the prevention...

EXPERT MEETING ON RAPID DIAGNOSTIC TESTS AND IMPLEMENTATION STRATEGIES FOR THE DENGUE VACCINE

by arnaud debuyzer | 25 May, 2022 | Epidemiology and biology, Scientific communication, Vaccine

Brainstorming on dengue vaccination with CYD-TDV (Dengvaxia®). In January 2019, the Partnership for Dengue Control (PDC) and the Global Dengue and Aedes-transmitted diseases Consortium (GDAC) organized a 3-day experts’ workshop hosted by the Mérieux Foundation at Les...

COMMUNICATION FOR THE INTRODUCTION OF THE VACCINE AGAINST HUMAN PAPILLOMA VIRUS IN MAURITANIA

by arnaud debuyzer | 25 May, 2022 | Communication for development, Operational research and evaluation, Social sciences for public health, Strategic and operational guidelines and tools, Vaccine

In Mauritania, tens of thousands of girls will soon be protected against cervical cancer. Mauritania is committed to protecting tens of thousands of young girls from cervical cancer every year through vaccination against human papillomavirus. EpiLinks supports...